Global Thoracic Aortic Stent Graft Market Size By Type (Metal, Polymer), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Thoracic Aortic Stent Graft Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.5 billion by 2031, growing at a CAGR of 9.8% during the forecast period from 2023 to 2031. Thoracic aortic stent grafts have become the cornerstone in the treatment of thoracic aortic aneurysms and dissections, replacing open surgical methods with minimally invasive alternatives. The market's expansion is driven by an aging global population, technological advancements in stent graft design, and the increasing incidence of aortic diseases.

Drivers:

1. Growing Geriatric Population:

The risk of thoracic aortic aneurysms increases with age. The rising number of elderly individuals globally is directly driving demand for stent graft procedures that offer lower mortality and morbidity compared to traditional surgery.

2. Technological Advancements in Stent Graft Design:

Modern thoracic stent grafts offer enhanced flexibility, precise deployment, and improved anatomical conformity. Innovations such as branched and fenestrated grafts are expanding the treatable patient population.

3. Increased Adoption of Endovascular Repair (TEVAR):

Thoracic Endovascular Aortic Repair (TEVAR) is gaining traction over open surgical repair due to shorter hospital stays, reduced recovery times, and fewer complications, supporting market growth.

Restraints:

1. High Procedure and Device Costs:

The high cost of stent grafts and endovascular procedures may restrict market growth, particularly in price-sensitive or underinsured populations and developing regions.

2. Complication Risks and Long-term Durability:

Despite advancements, complications such as endoleaks, graft migration, or reinterventions remain concerns. Uncertainty about long-term durability can also limit broader adoption.

Opportunity:

1. Untapped Emerging Markets:

Countries across Asia-Pacific and Latin America offer significant growth potential due to improving healthcare infrastructure, rising healthcare awareness, and expanding medical reimbursement frameworks.

2. Increasing Use in Complex and Emergency Procedures:

The ongoing refinement of imaging technologies and device platforms is enabling the application of TEVAR in more complex cases, including trauma and dissections, further fueling demand.

Market by System Type Insights:

Based on system type, Standard Stent Grafts held the largest share in 2023 due to their broad applicability in treating aneurysms. However, the Branched and Fenestrated Stent Grafts segment is expected to grow the fastest during the forecast period. These advanced grafts address anatomically challenging cases and expand therapeutic options for surgeons.

Market by End-use Insights:

Hospitals accounted for the largest market share in 2023, driven by the high volume of surgical procedures and availability of specialized vascular surgeons and facilities. Ambulatory Surgical Centers (ASCs) are emerging as a significant growth segment due to the minimally invasive nature of TEVAR, supporting shorter recovery times and outpatient management.

Market by Regional Insights:

North America dominated the global thoracic aortic stent graft market in 2023, backed by advanced healthcare infrastructure, high disease awareness, and favorable reimbursement policies. Asia-Pacific is expected to record the highest CAGR during the forecast period due to increasing investments in vascular health, the prevalence of aortic diseases, and technological adoption in countries like China, India, and Japan.

Competitive Scenario:

Leading players in the thoracic aortic stent graft market include Medtronic, Cook Medical, W. L. Gore & Associates, Terumo Corporation, Endologix LLC, Cardinal Health, and MicroPort Scientific Corporation. These companies focus on R&D, product innovation, regulatory approvals, and geographic expansion.

Key Developments:

In 2023, Medtronic received FDA approval for its latest generation branched thoracic stent graft, optimized for aortic arch anatomy.

W. L. Gore & Associates expanded its clinical trials in 2024 to assess long-term durability of its next-gen endoprosthesis.

Terumo launched a low-profile delivery system in Europe in 2025, targeting patients with smaller femoral access routes.

Scope of Work – Global Thoracic Aortic Stent Graft Market

Report Metric Details

Market Size (2023) USD 2.1 Billion

Projected Market Size (2031) USD 4.5 Billion

CAGR (2023–2031) 9.8%

Market Segments By System Type, End-use, Region

Growth Drivers Aging population, TEVAR adoption, device innovation

Opportunities Emerging markets, expanded clinical indications

FAQs:

1) What is the current market size of the Global Thoracic Aortic Stent Graft Market?

The market size was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Thoracic Aortic Stent Graft Market?

The major driver is the rising adoption of TEVAR due to its minimally invasive benefits and improved patient outcomes.

3) Which is the largest region during the forecast period in the Global Thoracic Aortic Stent Graft Market?

North America held the largest share in 2023, while Asia-Pacific is projected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Thoracic Aortic Stent Graft Market?

Standard Stent Grafts accounted for the largest market share in 2023.

5) Who are the key market players in the Global Thoracic Aortic Stent Graft Market?

Key players include Medtronic, Cook Medical, W. L. Gore & Associates, Terumo Corporation, and Endologix LLC.